These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6996606)

  • 1. Enzymatic targets in virus chemotherapy.
    Helgstrand E; Oberg B
    Antibiot Chemother (1971); 1980; 27():22-69. PubMed ID: 6996606
    [No Abstract]   [Full Text] [Related]  

  • 2. The Garrod lecture 1984. Strategies of antiviral chemotherapy.
    Stuart-Harris C
    J Antimicrob Chemother; 1985 Apr; 15(4):387-97. PubMed ID: 2409067
    [No Abstract]   [Full Text] [Related]  

  • 3. A high-throughput screening assay for simultaneous selection of inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate synthase (Dxs) or 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr).
    Humnabadkar V; Jha RK; Ghatnekar N; De Sousa SM
    J Biomol Screen; 2011 Mar; 16(3):303-12. PubMed ID: 21335601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral therapy targeting viral polymerase.
    Tsai CH; Lee PY; Stollar V; Li ML
    Curr Pharm Des; 2006; 12(11):1339-55. PubMed ID: 16611119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.
    Furuta Y; Komeno T; Nakamura T
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):449-463. PubMed ID: 28769016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of DNA polymerase and nucleotide analog triphosphates.
    Frank KB; Chiou JF; Cheng YC
    Adv Enzyme Regul; 1985; 24():377-84. PubMed ID: 3012971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of nucleoside analog inhibitors of herpesvirus polymerases.
    Prisbe EJ; Chen MS
    Methods Enzymol; 1996; 275():425-40. PubMed ID: 9026653
    [No Abstract]   [Full Text] [Related]  

  • 8. [Substrate specificity of T4 RNA-ligase. The role of phosphate nucleotide residues in the formation of a covalent AMP-RNA-ligase complex].
    Iuodka BA; Labeĭkite DIa; Sasnauskene SI
    Biokhimiia; 1991 May; 56(5):798-805. PubMed ID: 1747409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor.
    Xiong H; Foulk M; Aschenbrenner L; Fan J; Tiong-Yip CL; Johnson KD; Moustakas D; Fleming PR; Brown DG; Zhang M; Ferguson D; Wu D; Yu Q
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6789-93. PubMed ID: 24211022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA topoisomerases as potential targets of antiviral action.
    Kreuzer KN
    Pharmacol Ther; 1989; 43(3):377-95. PubMed ID: 2554345
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral and host-cell protein kinases: enticing antiviral targets and relevance of nucleoside, and viral thymidine, kinases.
    Shugar D
    Pharmacol Ther; 1999; 82(2-3):315-35. PubMed ID: 10454209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral encoded enzymes of nucleic acid metabolism and their role in the development of antiviral agents.
    Shugar D
    Prog Clin Biol Res; 1982; 102 Pt C():127-38. PubMed ID: 6132398
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of viral polymerases by chain-terminating substrates: a kinetic analysis.
    Wilson JE; Porter DJ; Reardon JE
    Methods Enzymol; 1996; 275():398-424. PubMed ID: 9026652
    [No Abstract]   [Full Text] [Related]  

  • 14. [Microbial secondary metabolites as inhibitors of pharmaceutically important transferases and oxidoreductases].
    Eva B; Mária S
    Ceska Slov Farm; 2012 Jun; 61(3):107-14. PubMed ID: 22913826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2001 ASPET Otto Krayer Award Lecture. Molecular targets for antiviral agents.
    De Clercq E
    J Pharmacol Exp Ther; 2001 Apr; 297(1):1-10. PubMed ID: 11259521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses.
    Brideau RJ; Knechtel ML; Huang A; Vaillancourt VA; Vera EE; Oien NL; Hopkins TA; Wieber JL; Wilkinson KF; Rush BD; Schwende FJ; Wathen MW
    Antiviral Res; 2002 Apr; 54(1):19-28. PubMed ID: 11888654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of herpes simplex virus-induced DNA polymerase, cellular DNA polymerase alpha, and virus production by aphidicolin.
    Dicioccio RA; Chadha K; Sahai Srivastava BI
    Biochim Biophys Acta; 1980 Sep; 609(2):224-31. PubMed ID: 6250617
    [No Abstract]   [Full Text] [Related]  

  • 18. Highlights in the development of new antiviral agents.
    De Clercq E
    Mini Rev Med Chem; 2002 Apr; 2(2):163-75. PubMed ID: 12370077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribavirin: recent insights into antiviral mechanisms of action.
    Reyes GR
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):651-6. PubMed ID: 12825459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative merits and drawbacks of new nucleoside analogues with clinical potential.
    Oberg B; Johansson NG
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():5-26. PubMed ID: 6436227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.